FDA Panel hears testimony on antidepressants

Opposing sides on whether antidepressants can prompt adults to attempt suicide are lined up to speak before a panel of scientific advisers to the FDA. The panel is considering whether to recommend forcing tough label warnings on widely used antidepressant medication, such as Lexapro and Zoloft.

For the full article.

Lawyer Monthly - Legal Awards Winner
The National Trial Lawyers
Elder Care Matters Alliance
American Association for Justice
Fellow Litigation Counsel of America
Super Lawyers